Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Adalimumab/secukinumab

Paradoxical palmoplantar pustulosis and treatment failure: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Shao X-Y, et al. A Patient with Adalimumab-Induced Refractory Paradoxical Palmoplantar Pustulosis Was Successfully Treated by Ixekizumab: A Case Report. Clinical, Cosmetic and Investigational Dermatology 16: 879-881, et al. Apr 2023. Available from: URL: http://doi.org/10.2147/CCID.S406164 Shao X-Y, et al. A Patient with Adalimumab-Induced Refractory Paradoxical Palmoplantar Pustulosis Was Successfully Treated by Ixekizumab: A Case Report. Clinical, Cosmetic and Investigational Dermatology 16: 879-881, et al. Apr 2023. Available from: URL: http://​doi.​org/​10.​2147/​CCID.​S406164
Metadaten
Titel
Adalimumab/secukinumab
Paradoxical palmoplantar pustulosis and treatment failure: case report
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45405-z

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Cenegermin

Case report

Methotrexate